Share

Dis-Chem exceeds R30bn revenue mark

Pharmaceutical retailer Dis-Chem saw improved earnings for the year until February. Backed by strong online sales and its acquisition strategy, group headline earnings per share were almost up by 30 per cent and revenue exceeded $30 billion. Joining CNBC Africa for more is Rui Moraish, Chief Financial Officer at Dis-Chem.
Mon, 23 May 2022 16:09:28 GMT